Skip to main content
. 2024 Apr 29;16(6):1427–1450. doi: 10.1038/s44321-024-00072-8

Figure EV4. GP64-LV half-life after systemic administration in mice.

Figure EV4

(A) Percentage of the serum concentrations of LV particles (measured as HIV Gag p24) recovered at the indicated time (minutes) after administration of GP64-LV or CD47hi GP64-LV relative to the total amount of administered LV particles to C57BL/6 or NOD mice, as indicated (8e10 TU/kg). Kruskal–Wallis test with Dunn’s multiple comparison test (compared to C57 LV). (B) Single values, mean, and SEM of the percentage of GFP-positive Huh7 cells, transduced with GP64-LV or CD47hi GP64-LV, at the indicated MOI (n = 3).